Covalon Technologies (OTCMKTS:CVALF) Trading Down 3% – Here’s Why

Covalon Technologies Ltd. (OTCMKTS:CVALF)’s share price traded down 3% on Wednesday . The company traded as low as $1.60 and last traded at $1.64. Approximately 23,085 shares were traded during trading, an increase of 1,863% from the average daily volume of 1,176 shares. The stock had previously closed at $1.69.

Covalon Technologies Trading Down 3.0%

The company has a market cap of $45.30 million, a P/E ratio of 41.01 and a beta of 0.59. The business’s fifty day moving average is $1.56 and its 200 day moving average is $1.43.

Covalon Technologies (OTCMKTS:CVALF) last posted its quarterly earnings data on Thursday, May 21st. The company reported $0.03 EPS for the quarter, beating the consensus estimate of $0.01 by $0.02. Covalon Technologies had a return on equity of 5.77% and a net margin of 5.05%.The business had revenue of $6.27 million for the quarter, compared to the consensus estimate of $6.70 million.

About Covalon Technologies

Covalon Technologies Ltd. (OTCMKTS:CVALF) is a Canadian medical device and life sciences company specializing in advanced wound care and infection prevention solutions. Based in Toronto, Ontario, Covalon leverages proprietary photochemical bonding technology to create antimicrobial and anti-adhesion polymer coatings for a range of medical devices and wound dressings. The company’s core focus is on reducing surgical site infections and improving healing outcomes through innovative biomaterials.

The company’s product portfolio comprises hydrogel-based wound dressings and polymer-coated medical device components.